Vir Biotechnology Inc. (VIR)
9.34
-0.01 (0.11%)
Upcoming Events
Latest Headlines
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
July 22, 2026 4:05 PM - BizWire
Form 144 Vir Biotechnology, Inc. Filed by: Ramasastry Saira
June 29, 2026 3:07 PM - SEC Filing
Vir Biotechnology (VIR) PT Raised to $27 at Morgan Stanley
June 11, 2026 8:24 AM - StreetInsider
Form 4 Vir Biotechnology, Inc. For: Jun 09 Filed by: Coughlin Timothy
June 10, 2026 6:21 PM - SEC Filing
Form 3 Vir Biotechnology, Inc. For: Jun 09 Filed by: Coughlin Timothy
June 10, 2026 6:20 PM - SEC Filing
Form 8-K Vir Biotechnology, Inc. For: Jun 09
June 10, 2026 4:28 PM - SEC Filing
Vir Biotechnology appoints Timothy Coughlin to board of directors
June 10, 2026 4:05 PM - StreetInsider
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
June 10, 2026 4:05 PM - BizWire
Form 4 Vir Biotechnology, Inc. For: Jun 01 Filed by: Napolitano Janet
June 2, 2026 5:35 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: Jun 01 Filed by: Sabatini Brent
June 2, 2026 5:32 PM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: Sabatini Brent
June 1, 2026 3:04 PM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: Napolitano Janet
June 1, 2026 1:05 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Sigal Charles Elliott
May 28, 2026 7:26 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Napolitano Janet
May 28, 2026 7:25 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: MORE ROBERT J
May 28, 2026 7:25 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Hatfield Jeffrey S.
May 28, 2026 7:25 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Farid Ramy
May 28, 2026 7:24 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: BISCHOFBERGER NORBERT W
May 28, 2026 7:24 PM - SEC Filing
Form 8-K Vir Biotechnology, Inc. For: May 25
May 28, 2026 9:01 AM - SEC Filing
Vir Biotechnology to present hepatitis delta trial data at EASL Congress
May 18, 2026 4:05 PM - StreetInsider
Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
May 18, 2026 4:05 PM - BizWire
Form SCHEDULE 13G/A Vir Biotechnology, Inc. Filed by: SB INVESTMENT ADVISERS (UK) LTD
May 15, 2026 9:00 PM - SEC Filing
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 14, 2026 11:12 AM - StreetInsider
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 14, 2026 10:55 AM - Globe NewsWire
Vir Biotechnology (VIR) PT Lowered to $23 at Morgan Stanley
May 8, 2026 8:11 AM - StreetInsider
Form 10-Q Vir Biotechnology, Inc. For: Mar 31
May 7, 2026 6:01 AM - SEC Filing
Form 8-K Vir Biotechnology, Inc. For: May 06
May 6, 2026 4:12 PM - SEC Filing
Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 75c, offers outlook
May 6, 2026 4:07 PM - StreetInsider
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 6, 2026 4:05 PM - BizWire
Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
May 5, 2026 4:05 PM - BizWire
Form 4 Vir Biotechnology, Inc. For: May 01 Filed by: SATO VICKI L
May 4, 2026 12:36 PM - SEC Filing
Form 4 Vir Biotechnology, Inc. For: Apr 29 Filed by: De Backer Marianne
April 30, 2026 5:43 PM - SEC Filing
Form 144 Vir Biotechnology, Inc. Filed by: Eisner Mark
April 30, 2026 10:20 AM - SEC Filing
Form SCHEDULE 13G Vir Biotechnology, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 3:50 PM - SEC Filing
Full Article List
